Terms: = Breast cancer AND RSPO3, Q9BXY4, THSD2, PWTSR, FLJ14440, CRISTIN1, ENSG00000146374, 84870
8 results:
1. R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
Ter Steege EJ; Doornbos LW; Haughton PD; van Diest PJ; Hilkens J; Derksen PWB; Bakker ERM
Cancer Lett; 2023 Aug; 568():216301. PubMed ID: 37406727
[TBL] [Abstract] [Full Text] [Related]
2. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
3. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and breast cancers.
Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
[TBL] [Abstract] [Full Text] [Related]
4. Dysregulation of cancer genes by recurrent intergenic fusions.
Yun JW; Yang L; Park HY; Lee CW; Cha H; Shin HT; Noh KW; Choi YL; Park WY; Park PJ
Genome Biol; 2020 Jul; 21(1):166. PubMed ID: 32631391
[TBL] [Abstract] [Full Text] [Related]
5. R-spondin3 Is Associated with Basal-Progenitor Behavior in Normal and Tumor Mammary Cells.
Tocci JM; Felcher CM; García Solá ME; Goddio MV; Zimberlin MN; Rubinstein N; Srebrow A; Coso OA; Abba MC; Meiss RP; Kordon EC
Cancer Res; 2018 Aug; 78(16):4497-4511. PubMed ID: 29748375
[TBL] [Abstract] [Full Text] [Related]
6. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract] [Full Text] [Related]
7. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract] [Full Text] [Related]
8. RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.
Recouvreux MS; Grasso EN; Echeverria PC; Rocha-Viegas L; Castilla LH; Schere-Levy C; Tocci JM; Kordon EC; Rubinstein N
Oncotarget; 2016 Feb; 7(6):6552-65. PubMed ID: 26735887
[TBL] [Abstract] [Full Text] [Related]
